Login / Signup

Dynamic Response of Donor-Derived Cell-Free DNA Following Treatment of Acute Rejection in Kidney Allografts.

Theresa K Wolf-DotyRoslyn B MannonEmilio D PoggioRandall J HinojosaDavid HillerJonathan S BrombergDaniel C Brennan
Published in: Kidney360 (2021)
dd-cfDNA may be a useful dynamic biomarker to assess the health of the kidney allograft following rejection treatment.
Keyphrases
  • healthcare
  • public health
  • risk assessment
  • drug induced
  • health information
  • climate change
  • aortic dissection